Treatment Response in Individual Organs Affected by Chronic Graft-Versus-Host Disease

Chronic graft-versus-host disease (GVHD) occurs in 30–70% of patients after allogeneic hematopoietic cell transplantation (HCT) and increases the risks of morbidity and mortality. Systemic corticosteroids are the standard initial treatment, but one-third of patients require subsequent treatment with...

Full description

Bibliographic Details

Published in:	Cells
Main Authors:	Takanobu Morishita, Paul J. Martin, Yoshihiro Inamoto
Format:	Article
Language:	English
Published:	MDPI AG 2025-02-01
Subjects:	keyword allogeneic hematopoietic cell transplantation chronic graft-versus-host disease organ response extracorporeal photopheresis ibrutinib ruxolitinib
Online Access:	https://www.mdpi.com/2073-4409/14/4/238